FIELD: medicine.
SUBSTANCE: high-molecular adiponectin is measured, and the measured level of high-molecular adiponectin of less than 4.6 mcg/ml is considered to be a risk factor of arterial hypertension. The sensitivity of the method makes 89.3%, while its specificity is 88.1%.
EFFECT: method enables determining the risk factor of arterial hypertension reliably in the females suffering from abdominal obesity.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING VITAMIN D LEVEL IN WOMEN WITH ABDOMINAL OBESITY AND HIGH RISK OF METABOLIC SYNDROME DEVELOPMENT | 2014 |
|
RU2560345C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ABDOMINAL OBESITY WITH A STABLE COURSE OF CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE II-III CLASS, WHO UNDERWENT MYOCARDIAL REVASCULARIZATION | 2022 |
|
RU2798728C1 |
METHOD FOR PREDICTION OF GESTATIONAL DIABETES MELLITUS IN FEMALES WITH ANDROIDS TYPE OF OBESITY | 2018 |
|
RU2686069C1 |
METHOD FOR PREDICTION OF DEVELOPING METABOLIC SYNDROME IN PATIENT SUFFERING ABDOMINAL OBESITY | 2010 |
|
RU2471193C2 |
METHOD FOR DETERMINING PROBABILITY OF ISCHEMIC HEART DISEASE IN YOUNG PATIENTS WITH ABDOMINAL OBESITY | 2020 |
|
RU2749293C1 |
METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
METHOD FOR FETOPLACENTAL INSUFFICIENCY PREDICTION IN PREGNANT WOMEN WITH ANDROIDS TYPE OF OBESITY | 2020 |
|
RU2738708C1 |
METHOD FOR PREDICTING EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN OBESE PATIENTS | 2017 |
|
RU2652550C1 |
METHOD OF CREATING A PERSONALIZED PROGRAM OF PREGRAVIDARY PREPARATION OF PATIENTS WITH INFERTILITY AND OBESITY FOR AUXILIARY REPRODUCTIVE TECHNOLOGIES | 2022 |
|
RU2796893C1 |
METHOD FOR PREDICTING MACROSOMIA IN PREGNANT WOMEN WITH ANDROID-TYPE OBESITY IN THE FIRST TRIMESTER OF PREGNANCY | 2021 |
|
RU2779994C1 |
Authors
Dates
2015-04-27—Published
2014-05-29—Filed